<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Circulation. Author manuscript; available PMC 2014 April 28. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Circulation. 2009 November 10; 120(19): 1883&#226;&#8364;&#8220;1892. doi:10.1161/CIRCULATIONAHA.108.837724. <br />  <br />  <br />  <br />                            Glycome Transcriptome Regulation Vasculogenesis <br />                            Rania Harfouche, PhD#, Dirk M. Hentschel, MD#, Stephanie Piecewicz, BS#, Sudipta Basu, <br />                            PhD, Cristin Print, MBChB, PhD, David Eavarone, BS, Tanyel Kiziltepe, PhD, Ram <br />                            Sasisekharan, PhD, Shiladitya Sengupta, PhD <br />                            Department Medicine (R.H., D.M.H., S.P., S.B., S.S.), Brigham Women&apos;s Hospital, Boston, <br />                            Mass; Department Molecular Medicine Pathology (C.P.), University Auckland, Auckland, <br />                            New Zealand; Department Biological Engineering (D.E., T.K., R.S.), Massachusetts Institute of <br />                            Technology, Cambridge, Mass; Harvard-MIT Division Health Sciences Technology <br />                            (R.H., S.P., S.B., D.E., T.K., R.S., S.S.), Cambridge, Mass. <br />                            #   These authors contributed equally work. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                  Background&#226;&#8364;&#8221;Therapeutic vasculogenesis emerging concept potentially be <br />                                  harnessed management ischemic pathologies. The present study elucidates potential <br />                                  coregulation vasculogenesis heparan sulfate glycosaminoglycan&#226;&#8364;&#8220;rich cell-surface <br />                                  glycome transcriptome. <br />  <br />                                  Methods Results&#226;&#8364;&#8221;Differentiation embryonic stem cells endothelial cells in <br />                                  vitro embryoid body paralleled amplification heparan sulfate glycosaminoglycan <br />                                  sulfation, correlates levels enzyme N-deacetylase/N-sulfotransferase 1 <br />                                  (NDST1). Small hairpin RNA&#226;&#8364;&#8220;mediated knockdown NDST1 modification heparan sulfate <br />                                  glycosaminoglycans embryonic stem cells heparinases sodium chlorate inhibited <br />                                  differentiation embryonic stem cells endothelial cells. This translated vivo <br />                                  zebrafish embryo model, genetic knockdown NDST1 resulted impaired <br />                                  vascularization characterized concentration-dependent decrease intersegmental vessel <br />                                  lumen large tail-vessel configuration, rescued use exogenous sulfated <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  heparan sulfate glycosaminoglycans. <span id='am-2' about='protege:TO' typeof='owl:Thing'>To</span> explore cross talk glycome the <br />                                  transcriptome vasculogenesis, identified microarray validated wild-type <br />                                  NDST1 knockdown&#226;&#8364;&#8220;associated gene-expression patterns zebrafish embryos. Temporal <br />                                  analysis 3 developmental stages critical vasculogenesis revealed cascade pathways that <br />                                  mediate glycocalyx regulation vasculogenesis. These pathways intimately connected <br />                                  cell signaling, cell <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span>survival</span>, cell fate determination. Specifically, demonstrated that <br />                                  forkhead box O3A/5 proteins insulin-like growth factor key downstream signals this <br />                                  process. <br />  <br />  <br />  <br />                            &#194;&#169; 2009 American Heart Association, Inc. <br />                            Correspondence Dirk M. Hentschel Shiladitya Sengupta, Room 317, 65 Landsdowne St, Cambridge, MA 02139. <br />                            shiladit@mit.edu dhentschel@partners.org. <br />                            The online-only Data Supplement available article http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA. <br />                            108.837724/DC1. Guest Editor article Daniel I. Simon, MD. <br />                            Disclosures <br />                             Harfouche et al.                                                                                             Page 2 <br />  <br />  <br />                                     Conclusions&#226;&#8364;&#8221;The present study time implicates interplay glycome and <br />                                     transcriptome vasculogenesis, revealing possibility harnessing specific cellular <br />                                     glyco-microenvironments therapeutic vascularization. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Keywords <br />                                     neovascularization; physiological; embryonic stem cells; zebrafish; vasculature; signal <br />                                     transduction; IGF-2 <br />  <br />                                               Promotion neovasculature holds potential ameliorating coronary artery disease, <br />                                               leading cause morbidity mortality United States.1 Although the <br />                                               focus inhibiting angiogenesis tumors, therapeutic angiogenesis emerging as <br />                                               exciting frontier cardiovascular medicine, recently articulated Ferrara and <br />                                               Kerbel.2 Indeed, physiological revascularization essential embryogenesis tissue <br />                                               regeneration, occurs wound healing, ischemia, after <br />                                               tissue transplantation. <br />  <br />                                               The formation neovasculature proceeds 2 distinct processes: vasculogenesis, the <br />                                               development primordial vasculature novo, angiogenesis, development of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               vasculature existing network.3 The prevalent dogma neovasculature the <br />                                               adult established primarily process angiogenesis; however, recent studies <br />                                               demonstrated endothelial progenitor cells promote neovascularization,4 <br />                                               presents paradigm vasculogenesis contributes therapeutic <br />                                               neovascularization adult. For example, Transplantation Of Progenitor Cells And <br />                                               Regeneration Enhancement Acute Myocardial Infarction (TOPCARE-AMI) trial <br />                                               indicated circulating endothelial progenitor cells improve left ventricular ejection <br />                                               fraction patients myocardial infarction improving neovascularization.5 Recent <br />                                               studies demonstrated embryonic stem cells (ES cells) differentiate into <br />                                               functional endothelial cells (ES-ECs) vasculogenesis process.6,7 <br />                                               Bioluminescence imaging showed longitudinal survival transplanted ES-ECs, whereas <br />                                               echocardiography demonstrated functional improvement arose increased <br />                                               neovascularization.8 The harnessing vasculogenesis potential revolutionize <br />                                               regenerative medicine contingent means regulate cellular differentiation. <br />  <br />                                               Although molecular mechanisms underlying vasculogenesis increasingly being <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               elucidated, limited knowledge exists role cellular glyco-microenvironment in <br />                                               process. Indeed, angiogenic factors fibroblast growth factor-2 vascular <br />                                               endothelial growth factor shown bind heparan sulfate glycosaminoglycans <br />                                               (HSGAGs), key component glyco-microenvironment.9,10 Similarly, recent <br />                                               study, decreased N-sulfation HSGAG chains reduce platelet-derived growth <br />                                               factor-BB&#226;&#8364;&#8220;induced pericyte recruitment vascular development.11 In present <br />                                               study, focused elucidating cross talk HSGAGs-glycome the <br />                                               transcriptome regulating vasculo-genesis, specifically differentiation ES cells into <br />                                               endothelium. HSGAGS linear N- O-sulfated biopolymers disaccharide units <br />                                               covalently linked glycosylphosphatidylinositol-anchored secreted proteins. They are <br />                                               posttranslationally sulfated Golgi apparatus various glycosynthetic enzymes, of <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                          Page 3 <br />  <br />  <br />                                               N-deacetylase/N-sulfotransferases (NDSTs) rate-limiting. We demonstrate that <br />                                               expression glycosynthetic enzyme NDST1 sulfation HSGAGs <br />                                               increase vasculogenesis. Furthermore, pharmacological modulation sulfation <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               <span id='am-238' about='xsp:pattern' typeof='owl:Thing'>pattern</span> knockdown NDST1 blocked vasculogenesis, rescued addition <br />                                               exogenous HSGAGs. We confirmed findings vivo larval zebrafish, which <br />                                               downregulation NDST1 resulted impaired vascular development. Finally, identified <br />                                               downstream pathways mediate regulation vasculogenesis by <br />                                               HSGAGs. The present study reveals exciting potential harnessing defined cellular <br />                                               glyco-microenvironments directed differentiation precursor cells adult tissue in <br />                                               vitro vivo. <br />  <br />  <br />                               Methods <br />                               Cell Culture <br />                                               Murine ES cells (129 substrain), obtained ATCC (Manassas, Va), differentiated <br />                                               leukemia inhibitory factor&#226;&#8364;&#8220;negative media seeding cells density 1600 cells/cm2 <br />                                               ultralow attachment conditions promote embryoid body formation. On specific <br />                                               days, equal number cells taken dish subjected real-time <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               polymerase chain reaction (RT-PCR), Western blotting, immunohistochemistry to <br />                                               monitor expression endothelial cell markers. <br />  <br />                               Enzymatic Chemical Modification Glycocalyx <br />                                               ES cell-surface HSGAGs modified treatment 10 mU/mL heparinase I, <br />                                               heparinase III, sodium chlorate. At end experiments, cells collected, <br />                                               washed PBS, analyzed endothelial differentiation RT-PCR, immunoblotting, <br />                                               immunohistochemistry. HSGAG modification characterized capillary <br />                                               electrophoresis. <br />  <br />                               Isolation Compositional Analysis ES Cell-Surface HSGAGs <br />                                               Cells trypsinized 30 minutes 37&#194;&#176;C harvest cell-surface HSGAGs. Cells were <br />                                               counted normalize cell number subsequent capillary electrophoresis analysis. <br />                                               HSGAGs purified ultrafree DEAE column. Eluted fragments were <br />                                               concentrated Centricon filters (molecular weight cutoff 3 kDa; Millipore Corp, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Billerica, Mass), freeze-dried overnight, digested 30&#194;&#176;C incubation 3 mIU <br />                                               heparinase I, II, III. Digested glycosaminoglycan fragments analyzed with <br />                                               Agilent 3-dimensional capillary electrophoresis 72-cm extended light path <br />                                               capillary 75-&#206;&#188;m inner diameter (Agilent Technologies, Santa Clara, Calif). Negative <br />                                               polarity separation monitored 235 nm 50 mmol/L Tris, 10 mmol/L dextran sulfate <br />                                               buffer, pH 2.5. Peaks assigned comparison standards. <br />  <br />                               Short Hairpin RNA Lentivirus Infection <br />                                               To selectively knock NDST1 forkhead box O3a (FOXO3A) ES cells, we <br />                                               infected cells using short hairpin RNAs (shRNAs) complementary NDST1, FOXO3A, or <br />                                               green fluorescent protein (GFP; gift Nir Hacohen, Center Immunology &amp; <br />                                               Inflammatory Diseases, Massachusetts General Hospital, Boston, Mass). These shRNA are <br />  <br />  <br />                                                    Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                            Page 4 <br />  <br />  <br />                                               inserted replication-deficient lentiviruses possess puromycin-resistant gene, which <br />                                               allows selection infected cells. Briefly, 24-hour-old embryoid bodies infected <br />                                               viruses 1 5 multiplicities infection presence polybrene transfection <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               reagent overnight. Fresh medium replenished 3 days. RNA harvested at <br />                                               specific time points infection subjected RT-PCR, described online-only <br />                                               Data Supplement. <br />  <br />                               Zebrafish Studies <br />                                               Zebrafish [T&#195;&#188;bingenAB tg(Fli:eGFP)] embryos maintained standard E3 solution <br />                                               buffered HEPES 2 mmol/L. A splice donor morpholino used inhibit the <br />                                               expression zebrafish NDST1. The morpholino sequence based 8 overlapping <br />                                               3&#226;&#8364;&#178;-exons 3 predicted open reading frames, &gt;50% identity human NDST1 on <br />                                               zebrafish genome assembly (Zv6 Sanger Institute Ensemble, Cambridge, United <br />                                               Kingdom; GenBank accession numbers XP_699032, XP_695253, XP_691043). The <br />                                               exon-3 splice donor morpholino predicted lead splicing exon 2 exon 4. <br />                                               Scrambled morpholinos used control. Increasing concentrations morpholinos <br />                                               injected 2-cell-stage embryos constant volume 4.6 nL Nanoject II <br />                                               (Drummond Scientific, Broomall, Pa). To test patency vessels, 4.6 nL 10% <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               tetramethylrhodamine-labeled 40-kDa dextran (Molecular Probes, Carlsbad, Calif) was <br />                                               injected cardiac venous sinus. Bright-field fluorescence images embryos <br />                                               captured Nikon SMZ1500 stereomicroscope SPOT Flex camera <br />                                               (Diagnostic Instruments, Inc, Sterling Heights, Mich). Image sequences obtained with <br />                                               setup exported movies match live flow patterns. All procedures were <br />                                               approved Harvard University&apos;s Institutional Animal Care Use Committee. <br />  <br />                               Affymetrix Oligonucleotide Gene Arrays <br />                                               Embryos injected NDST1 morpholino wild-type siblings harvested at <br />                                               6- 20-somite developmental stages 24 hours fertilization (hpf). Total RNA <br />                                               extracted TRIzol reagent (Invitrogen, Carlsbad, Calif) purified Qiagen <br />                                               RNeasy columns (Qiagen, Valencia, Calif). Hybridization Affymetrix zebrafish genome <br />                                               arrays data acquisition performed Harvard Medical School Partners <br />                                               Healthcare Center Genetics Genomics. Quality control GeneChip <br />                                               Operating Software (GCOS; Affymetrix, Santa Clara, Calif) DNA-Chip Analyzer <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               (dChip).11a Acquired probe-level data normalized robust multichip average <br />                                               method, mean log 2 expression intensities triplicate experiments used in <br />                                               subsequent differential analysis. Local pooled error ANOVA differential expression <br />                                               testing performed S-Plus (Tibco Software, Palo Alto, Calif), P&lt;0.05 and <br />                                               Bonferroni Benjamini-Hochberg corrections applied define significant genes and <br />                                               limit false-positive results, respectively. Regulated transcripts investigated use <br />                                               modified t test, R version Cyber-T algorithm. Gene pathways based on <br />                                               transcripts regulated robust multichip average method MAS5 data of <br />                                               3 time points Cyber-T fold-change criteria described defined with <br />                                               Cell Illustrator software Ingenuity Pathways Analysis (Ingenuity Systems, Inc, <br />                                               Redwood City, Calif). Independent component analysis performed MATLAB <br />                                               software (The MathWorks, Natick, Mass; online-only Data Supplement). Affymetrix <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                            Page 5 <br />  <br />  <br />                                               probe sets annotated basis gene symbols available Affymetrix <br />                                               Netaffix World Wide Web site, Entrez Gene, Unigene, GenBank, Boston Trans-NIH <br />                                               Zebrafish Genome Initiative. Undefined transcripts identified Affymetrix probe IDs. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               A subset differential transcript abundance confirmed RT-PCR. <br />  <br />                               Statistical Analysis <br />                                               All results expressed mean&#194;&#177;SEM triplicate samples. Statistical <br />                                               comparisons obtained 1-way ANOVA followed Newman-Keuls post hoc test. <br />                                               Tests performed PRISM software (GraphPad Software, San Diego, Calif). <br />                                               Statistical comparisons 2 groups obtained Student t test. P&lt;0.05 was <br />                                               considered significant. <br />  <br />  <br />                               Results <br />                               ES Cells Differentiate Into Endothelial Cells <br />                                               In present study, selected well-characterized embryonic stem cell&#226;&#8364;&#8220;embryoid body <br />                                               (ESC-EB), closely mimics vivo maturation process, vitro model to <br />                                               study vasculogenesis. When grown ultralow adherent conditions absence of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               leukemia inhibitory factor, ES cells start forming solid morula-like structures 2 days, <br />                                               progressively increase size finally cavitated (Figure 1B). As shown in <br />                                               Figure 1A, expression levels endothelial cell markers VE-cadherin, VEGFR2 <br />                                               (vascular endothelial growth factor receptor-2), von Willebrand factor, Tie-2, and <br />                                               angiopoietin-2 increased, expression stem cell marker Oct 4 decreased <br />                                               progressively 10-day period, consistent differentiation vascular <br />                                               endothelial cells. Confocal imaging immunolabeling ESCEBs von <br />                                               Willebrand factor revealed negligible signal day 3 progressively increased time <br />                                               (Figure 1B). These findings consistent previous reports12 increase in <br />                                               endothelial cell markers observed day 3 differentiation. Hemangioblast <br />                                               precursors established time point, coincides onset of <br />                                               vasculogenesis mouse embryo.13 <br />  <br />                               HSGAG Synthesis Is Upregulated During ES Cell Differentiation <br />                                               Differentiation ES cells endothelial cells paralleled increase NDST1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               transcripts protein, key regulator sulfation modification nascent <br />                                               HSGAG chain (Figure 1C 1D).14 To investigate functional implication NDST1 <br />                                               expression, analyzed compositional changes cell-surface HSGAG ESC-EB <br />                                               differentiation using reverse-polarity capillary electrophoresis. Interestingly, an <br />                                               increase higher-order sulfated HSGAGs fragments ESC-EB differentiation <br />                                               (Figure 1E), indicates involvement glycocalyx vasculogenic process. <br />  <br />                               HSGAGs Modulate Differentiation ES Cells Into Endothelial Cells <br />                                               HSGAGs biopolymers disaccharide units uronic acid glucosamine be <br />                                               sulfated 3 residues (Figure 2A). Treatment sodium chlorate indirectly blocks the <br />                                               sulfation HSGAG competitively inhibiting formation 3&#226;&#8364;&#178;-phosphoadenosine-5&#226;&#8364;&#178;- <br />                                               phosphosulfate, high-energy sulfate donor cellular sulfation reactions.15 As shown in <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                             Page 6 <br />  <br />  <br />                                               Figure 2B, capillary electrophoresis cell-surface HSGAGs demonstrates absence of <br />                                               sulfated disaccharide peaks 7 days treatment sodium chlorate compared with <br />                                               untreated control cells. This inhibition paralleled concentration-dependent decrease <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               protein expression endothelial cell marker von Willebrand factor (Figure 2C). <br />                                               Interestingly, expression endothelial cell marker restored the <br />                                               addition exogenous heparin (Figure 2D), establishes causal link between <br />                                               HSGAGs endothelium formation novo. This validated treatment of <br />                                               differentiating cells heparinase I III, digest HSGAGs regions of <br />                                               high low sulfation, respectively,16 resulted significant downregulation of <br />                                               endothelial cell markers (Figure 2E 2H; online-only Data Supplement Figure I). To <br />                                               confirm role HSGAGS ES differentiation endothelial cells, knocked <br />                                               HSGAG-modifying enzyme NDST1 ES cells using NDST1 shRNA. As shown <br />                                               Figure 2I, resulted 80% knockdown NDST1, translated significant <br />                                               reduction endothelial markers Tie-2, von Willebrand factor, angiopoietin-2, <br />                                               directly implicating NDST1 differentiation ES cells endothelial lineage. <br />  <br />                               Suppression NDST1 Leads Aberrant Vasculature Formation Zebrafish Embryo <br />                                               To validate present vitro results in vivo system, adopted strategy wherein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               genetically manipulated HSGAG synthesis zebrafish embryos. BLAST (Basic Local <br />                                               Alignment Search Tool) analysis revealed zebrafish ortholog NDST1 chromosome <br />                                               21 (Figure 3I). Given variety predicted ATG initiation sites locus, splice donor <br />                                               morpholino designed exon shared 3&#226;&#8364;&#178;-end exons common 3 <br />                                               predicted transcripts. To confirm effectiveness morpholino, designed specific <br />                                               primers RT-PCR RNA prepared injected control 72-hpf embryos. <br />                                               Sequencing subcloned fragments confirmed altered splicing resulted a <br />                                               premature stop codon. To confirm morpholino resulted attenuation of <br />                                               HSGAG sulfation, harvested cell-surface HSGAGs 24-hpf embryos and <br />                                               subjected compositional analysis using capillary electrophoresis. As shown in <br />                                               Figure 3 (II), NDST1 knockdown resulted significant reduction sulfated <br />                                               disaccharides. <br />  <br />                                               As seen Figure 3 (III), morpholino-induced knockdown NDST1 resulted in <br />                                               concentration-dependent aberrant formation dorsal aorta, caudal vein, intersegmental <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               vessels, contributed shortened, dysmorphic tails. Although higher <br />                                               concentrations morpholino resulted complete ablation blood flow the <br />                                               cloacae resulted dysmorphic tails, lower concentrations produced proximal <br />                                               confluence dorsal aorta posterior cardinal vein. Although lower concentrations <br />                                               induced vascular abnormalities, shortening tail observed, suggests that <br />                                               dysmorphic tail secondary result primary abnormal vascularization. In these <br />                                               cases, stagnant blood cells space usually occupied caudal vein <br />                                               plexus moved synchronously heartbeat (Figure 3 [IIIB]; online-only Data <br />                                               Supplement Movie I). These findings consistent T&#195;&#188;bingenAB and <br />                                               tg(Fli:GFP) embryos. Decreased vascular blood flow zNDST1 embryos associated <br />                                               smaller vessel lumen, evident injection 40 kDa tetramethylrhodamine- <br />                                               labeled dextran. <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                                Page 7 <br />  <br />  <br />                               Exogenous Sulfated HSGAGs Rescues Impaired Vascular <span id='am-159' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-160' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-162' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span>Phenotype</span> <br />                                               To test exogenous sulfated HSGAGs induce recovery vascular phenotype, we <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               treated NDST1 knockdown cells heparin, highly sulfated HSGAG analog. <br />                                               As shown Figure 4, treatment heparin increased endothelium-specific transcripts. <br />                                               Furthermore, heparin induced partial recovery phenotype NDST1-knockdown <br />                                               zebrafish (Figure 4B). <br />  <br />                               Glycocalyx Modifications Modulate Transcriptome Signatures Developing Zebrafish <br />                               Embryo <br />                                               To elucidate glycocalyx-mediated effects transcriptome regulators vasculogenesis, we <br />                                               performed global gene-expression analysis zNDST1 morphants wild-type siblings at <br />                                               6-somite, 20-somite, 24-hpf time points, correspond significant stages of <br />                                               zebrafish vessel development (migration angioblasts midline, major lateral vessel <br />                                               formation, intersegmental angiogenesis).17 The local pooled error method used to <br />                                               identify differentially expressed transcripts zNDST1 mutants wild-type siblings <br />                                               3 developmental stages, revealed 218 significant transcripts (corrected P value <br />                                               &lt;0.05, fold-change &lt;0.75 &gt;1.25; online-only Data Supplement Table I). Hierarchal <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               clustering Euclidean distance metric demonstrated distinct temporal expression <br />                                               patterns 50 transcripts (Figure 5A). Independent component analysis confirmed <br />                                               local pooled error analysis, 93% transcripts identified being <br />                                               differentially expressed local pooled error analysis 0.5% of <br />                                               transcripts contributed NDST1-associated ICA component 2 (Figure 5B). This <br />                                               Independent Component Analysis component 2 additionally identified 34 genes <br />                                               associated NDST knockdown (online-only Data Supplement Table V). ANOVA <br />                                               analysis MAS5-normalized data used define significant changes gene <br />                                               transcription comparison developmental stages (Benjamini-Hochberg corrected P <br />                                               value &lt;0.05; online-only Data Supplement Table II). Notably, greater number of <br />                                               significant transcripts 20-somite stage (619) 6-somite stage <br />                                               (67) 24 hpf (119), shown Figure 5C. Regulated genes significant cell <br />                                               signaling, transcription factors, cell proliferation/differentiation, protein stability, apoptosis, <br />                                               matrix interactions highlighted Figure 5D. Finally, data log <span id='am-237' about='xsp:base' typeof='owl:Thing'>base</span> 2 <br />                                               transformed, normalized MAS5 robust multichip average methods, then <br />                                               analyzed Cyber-T (P&#226;&#8240;&#164;0.05, mean fold-change &#226;&#8240;&#164;2 NDST1 morphant and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               wild type; online-only Data Supplement Tables III IV). As ANOVA method, <br />                                               analysis, 20-somite stage differentially regulated transcripts, <br />                                               overlapping transcripts existed different stages (Figure 6A). <br />                                               Pathway analysis based regulated transcripts developmental stage revealed <br />                                               interconnected networks regulate apoptosis, differentiation, cell matrix, cell-cell <br />                                               interaction (Figure 6B 6D). <br />  <br />  <br />                               Discussion <br />                                               In present study, focused roles glycosaminoglycan component the <br />                                               cell-surface glycome modulating vasculogenesis. As step, recapitulated <br />                                               vasculogen esis ESC-EBs. The primary vascular plexus formed embryonic body <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                           Page 8 <br />  <br />  <br />                                               undergoes remodeling day 6 7 onward sprouting angiogenesis.12,13 Interestingly, <br />                                               comparison compositional analysis cell-surface HSGAGs day 3 day <br />                                               7 ESC-EB revealed distinct profiles led increase highly sulfated disaccharide <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               residues differentiation. These sulfate residues introduced nascent polymer <br />                                               series sequential enzyme-induced modifications. The bifunctional activity of <br />                                               NDST family appears key regulator process, other <br />                                               modifications, namely, C5 epimerization 2O, 3O, 6O sulfations, predominate <br />                                               N-sulfated regions. Interestingly, mRNA transcripts total NDST1 <br />                                               protein levels upregulated vasculogenesis, explain increased <br />                                               sulfation HSGAG polymer. There 4 isoforms NDST distinct tissue <br />                                               distribution,18 NDST1 NDST2 isoforms expressed vasculature.19 <br />                                               In separate study, Johnson et al20 demonstrated similar upregulation NDST4 <br />                                               isoform ESC-EBs directed differentiate neural lineage. These <br />                                               observations implicate HSGAG synthetic enzymes differentiation process, which <br />                                               indicates postpolymerization modifications introduced nascent chains could <br />                                               play critical roles differentiation process specific lineages. <br />  <br />                                               To test hypothesis further, used morpholino-based approach knock the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               expression NDST1 developing zebrafish embryo model, emerged an <br />                                               excellent study vasculogenesis transparent embryo allows real- <br />                                               time functional monitoring evolving vasculature.21 In previous study, genetic <br />                                               perturbation HSGAG synthesis resulted early developmental defects, including <br />                                               failure differentiate mesodermal precursors endothelium,22,23 prevented <br />                                               characterization vasculogenesis studies. This limitation overcome <br />                                               zebrafish model, real-time monitoring embryo revealed the <br />                                               oligonucleotide-induced knockdown NDST1 resulted reduction HSGAG sulfation, <br />                                               led abnormal vasculature stunting tail, consistent hypothesis <br />                                               glycocalyx implicated vasculogenesis. Additionally, shRNA knockdown of <br />                                               NDST1 significantly suppressed expression endothelial markers embryoid <br />                                               bodies. This supported fact treatment differentiating embryoid <br />                                               bodies heparinase I III resulted inhibition vasculogenesis. Similarly, sodium <br />                                               chlorate, prevents sulfation nascent polymer, blocked vasculogenesis. This <br />                                               validated partial recovery endothelial phenotype the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               embryoid body zNDST1-knockdown zebrafish addition exogenous <br />                                               heparin, highly sulfated HSGAG analog. These results implicate causal link <br />                                               glycome composition endothelium formation. <br />  <br />                                               In previous study, demonstrated cellular pheno-type coregulated the <br />                                               cross talk glycome transcriptome.24 Interestingly, Jakobsson et al25 <br />                                               demonstrated HSGAGs expressed perivascular smooth muscle cells support <br />                                               development capillary structures NDST1/2-/- embryonic stem cells, which <br />                                               suggests just endothelial cell-surface HSGAGs glycocalyx the <br />                                               surrounding cellular architecture exert &#226;&#8364;&#339;bystander effect&#226;&#8364;? modulating <br />                                               vasculogenesis. We decided globally knock NDST1 study effect <br />  <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                             Page 9 <br />  <br />  <br />                                               transcriptome, developed mechanistic models based differentially <br />                                               regulated transcripts implicated neovascularization. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Not surprisingly, large number genes differentially regulated those <br />                                               involved signal transduction morphogenesis transcription factors (see the <br />                                               online-only Data Supplement details). For example, spleen tyrosine kinase (SYK) was <br />                                               upregulated NDST1knockdown embryos. SYK candidate tumor-suppressor gene that <br />                                               implicated suppression cyclin D1.26 It suppresses cell motility inhibiting <br />                                               phosphoinositide-3 kinase activity urokinase-type plasminogen activator secretion, <br />                                               critical neovascularization.27 Interestingly, phosphoinositide-3 kinase also <br />                                               negatively regulates FOXO, described below. We observed downregulation of <br />                                               Wnt receptor, Frizzled, NDST1-knockdown embryos, morphogen, <br />                                               sonic hedgehog (Shh). Previous studies zebrafish revealed vascular defects in <br />                                               Shh-mutant embryos.28 <br />  <br />                                               Interestingly, despite implication HSGAGs involved vascular endothelial <br />                                               growth factor, fibroblast growth factor, platelet-derived growth factor signaling in <br />                                               angiogenesis,8&#226;&#8364;&#8220;10 signals directly modulated NDST1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               knockdown embryos. Instead, transcription factor FOXO5 (zebrafish ortholog FOXO3A) <br />                                               insulin-like growth factor-2 (IGF2) consistently upregulated 3 <br />                                               time points. In elegant study, Potente et al29 demonstrated vivo FOXO3A <br />                                               deficiency increased vessel formation maturation. We dissected pathway in <br />                                               embryoid body model. As shown Figure 7, observed FOXO3A levels <br />                                               decreased cells differentiated endothelial cells. Interestingly, shRNA-mediated <br />                                               knockdown NDST1 increased FOXO3A transcript protein expression, which <br />                                               suggests FOXO3A downstream signal glycome modification. Furthermore, <br />                                               shRNA-mediated knockdown FOXO3A embryoid bodies resulted decreased <br />                                               IGF2 transcripts, suggests IGF2 modulated FOXO. Indeed, is <br />                                               evidence bidirec tional signaling IGFs FOXO.30 A recent study has <br />                                               demonstrated self-renewal pluripotent properties ES cells require IGF <br />                                               signaling.31 In contrast, study demonstrated IGF2 implicated homing of <br />                                               endothelial progenitor cells.32 This indicates regulation IGF activity differentiation <br />                                               progenitor cells endothelial cells, warrants studies. Although additional <br />                                               pathways coordinating glycome-transcriptome cross talk vasculogenesis, the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               present results clearly implicate FOXOIGF signaling axis process. <br />  <br />                                               In conclusion, clearly demonstrate involvement HSGAGs, key components of <br />                                               cell-surface glycome, vasculo-genesis. Furthermore, elucidated the <br />                                               critical downstream pathways implicated mediating glycome regulation of <br />                                               vasculogenesis. This study reveals exciting potential harnessing defined cellular <br />                                               glycomicroenvironments directed differentiation precursor cells therapeutic <br />                                               neovascularization. <br />  <br />                                               None. <br />  <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                                       Page 10 <br />  <br />  <br />                               Supplementary Material <br />                                               Refer Web version PubMed Central supplementary material. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Acknowledgments <br />                                               Sources Funding <br />  <br />                                               Dr Sengupta supported Scientist Development Grant American Heart Association a <br />                                               Department Defense Breast Cancer Research Program Era Hope Scholar Award. Dr Harfouche supported <br />                                               Canadian Institutes Health Research postdoctoral fellowship. <br />  <br />  <br />                               References <br />                                               1. Heart disease stroke statistics&#226;&#8364;&#8221;2007 update: report American Heart Association <br />                                                  Heart Statistics Committee Stroke Statistics Subcommittee. Circulation. 2007; 115:e69&#226;&#8364;&#8220;e171. <br />                                                  [PubMed: 17194875] <br />                                               2. Ferrara N, Kerbel RS. Angiogenesis therapeutic target. Nature. 2005; 438:967&#226;&#8364;&#8220;974. [PubMed: <br />                                                  16355214] <br />                                               3. Risau W. Mechanisms angiogenesis. Nature. 1997; 386:671&#226;&#8364;&#8220;674. [PubMed: 9109485] <br />                                               4. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, <br />                                                  Itescu S. Neovascularization ischemic myocardium human bone-marrow-derived angioblasts <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                  prevents cardiomyocyte apoptosis, reduces remodeling improves cardiac function. Nat Med. <br />                                                  2001; 7:430&#226;&#8364;&#8220;436. [PubMed: 11283669] <br />                                               5. Sch&#195;&#164;chinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, <br />                                                  Hofmann WK, Martin H, Dimmeler S, Zeiher AM. Transplantation progenitor cells and <br />                                                  regeneration enhancement acute myocardial infarction: final one-year results TOPCARE- <br />                                                  AMI Trial. J Am Coll Cardiol. 2004; 44:1690&#226;&#8364;&#8220;1699. [PubMed: 15489105] <br />                                               6. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, <br />                                                  Nishikawa S. Flk1-positive cells derived embryonic stem cells serve vascular progenitors. <br />                                                  Nature. 2000; 408:92&#226;&#8364;&#8220;96. [PubMed: 11081514] <br />                                               7. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived human <br />                                                  embryonic stem cells. Proc Natl Acad Sci U S A. 2002; 99:4391&#226;&#8364;&#8220;4396. [PubMed: 11917100] <br />                                               8. Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP, Wu <br />                                                  JC. Differentiation, survival, function embryonic stem cell derived endothelial cells for <br />                                                  ischemic heart disease. Circulation. 2007; 116(suppl):I&#226;&#8364;&#8220;46&#226;&#8364;&#8220;I-54. <br />                                               9. Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M, Claesson-Welsh L. Selectively <br />                                                  desulfated heparin inhibits fibroblast growth factor-induced mitogenicity angiogenesis. J Biol <br />                                                  Chem. 2000; 275:24653&#226;&#8364;&#8220;24660. [PubMed: 10816596] <br />                                               10. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. The binding vascular endothelial growth <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                    factor receptors dependent cell surface-associated heparin-like molecules. J Biol Chem. <br />                                                    1992; 267:6093&#226;&#8364;&#8220;6098. [PubMed: 1556117] <br />                                               11. Abramsson A, Kurup S, Busse M, Yamada S, Lindblom P, Schallmeiner E, Stenzel D, Sauvaget D, <br />                                                    Ledin J, Ringvall M, Landegren U, Kjell&#195;&#169;n L, Bondjers G, Li JP, Lindahl U, Spillmann D, <br />                                                    Betsholtz C, Gerhardt H. Defective N-sulfation heparan sulfate proteoglycans limits PDGF-BB <br />                                                    binding pericyte recruitment vascular development. Genes Dev. 2007; 21:316&#226;&#8364;&#8220;331. <br />                                                    [PubMed: 17289920] <br />                                               11a. Li C, Wong H. Model-based analysis oligonucleotide arrays: expression index computation and <br />                                                      outlier detection. Proc Natl Acad Sci. 2001; 98:31&#226;&#8364;&#8220;36. [PubMed: 11134512] <br />                                               12. Evans AL, Bryant J, Skepper J, Smith SK, Print CG, Charnock-Jones DS. Vascular development in <br />                                                    embryoid bodies: quantification transgenic intervention antiangiogenic treatment. <br />                                                    Angiogenesis. 2007; 10:217&#226;&#8364;&#8220;226. [PubMed: 17577673] <br />                                               13. Nakagami H, Nakagawa N, Takeya Y, Kashiwagi K, Ishida C, Hayashi S, Aoki M, Matsumoto K, <br />                                                    Nakamura T, Ogihara T, Morishita R. Model vasculogenesis embryonic stem cells for <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                                  Page 11 <br />  <br />  <br />                                                   vascular research regenerative medicine. Hypertension. 2006; 48:112&#226;&#8364;&#8220;119. [PubMed: <br />                                                   16754788] <br />                                               14. Grobe K, Ledin J, Ringvall M, Holmborn K, Forsberg E, Esko JD, Kjell&#195;&#169;n L. Heparan sulfate and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   development: differential roles N-acetylglucosamine N-deacetylase/N-sulfotransferase <br />                                                   isozymes. Biochim Biophys Acta. 2002; 1573:209&#226;&#8364;&#8220;215. [PubMed: 12417402] <br />                                               15. Delehedde M, Seve M, Sergeant N, Wartelle I, Lyon M, Rudland PS, Fernig DG. Fibroblast <br />                                                   growth factor-2 stimulation p42/44MAPK phosphorylation IkappaB degradation is <br />                                                   regulated heparan sulfate/heparin rat mammary fibroblasts. J Biol Chem. 2000; 275:33905&#226;&#8364;&#8220; <br />                                                   33910. [PubMed: 10944532] <br />                                               16. Ernst S, Langer R, Cooney CL, Sasisekharan R. Enzymatic degradation glycosaminoglycans. <br />                                                   Crit Rev Biochem Mol Biol. 1995; 30:387&#226;&#8364;&#8220;444. [PubMed: 8575190] <br />                                               17. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. Cellular molecular analyses vascular <br />                                                   tube lumen formation zebrafish. Development. 2005; 132:5199&#226;&#8364;&#8220;5209. [PubMed: 16251212] <br />                                               18. Iozzo RV. Basement membrane proteoglycans: cellar ceiling. Nat Rev Mol Cell Biol. <br />                                                   2005; 6:646&#226;&#8364;&#8220;656. [PubMed: 16064139] <br />                                               19. Esko JD, Selleck SB. Order chaos: assembly ligand binding sites heparan sulfate. Annu <br />                                                   Rev Biochem. 2002; 71:435&#226;&#8364;&#8220;471. [PubMed: 12045103] <br />                                               20. Johnson CE, Crawford BE, Stavridis M, Ten Dam G, Wat AL, Rushton G, Ward CM, Wilson V, <br />                                                   van Kuppevelt TH, Esko JD, Smith A, Gallagher JT, Merry CL. Essential alterations heparan <br />                                                   sulfate differentiation embryonic stem cells Sox1-enhanced green fluorescent <br />                                                   protein-expressing neural progenitor cells. Stem Cells. 2007; 25:1913&#226;&#8364;&#8220;1923. [PubMed: 17464092] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               21. Kidd KR, Weinstein BM. Fishing novel angiogenic therapies. Br J Pharmacol. 2003; 140:585&#226;&#8364;&#8220; <br />                                                   594. [PubMed: 14534143] <br />                                               22. Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, Matzuk MM. Disruption gastrulation and <br />                                                   heparin sulfate biosynthesis EXT1-deficient mice. Dev Biol. 2000; 224:299&#226;&#8364;&#8220;311. [PubMed: <br />                                                   10926768] <br />                                               23. Stickens D, Zak BM, Rougier N, Esko JD, Werb Z. Mice deficient Ext2 lack heparan sulfate and <br />                                                   develop exotoses. Development. 2005; 132:5055&#226;&#8364;&#8220;5068. [PubMed: 16236767] <br />                                               24. Johnson NA, Sengupta S, Saidi SA, Lessan K, Charnock-Jones SD, Scott L, Stephens R, Freeman <br />                                                   TC, Tom BD, Harris M, Denyer G, Sundaram M, Sasisekharan R, Smith SK, Print CG. <br />                                                   Endothelial cells preparing die apoptosis initiate program transcriptome glycome <br />                                                   regulation. FASEB J. 2004; 18:188&#226;&#8364;&#8220;190. [PubMed: 14630703] <br />                                               25. Jakobsson Kreuger J, Holmborn K, Lundin L, Eriksson I, Kjell&#195;&#169;n L, Claesson-Welsh L. Heparan <br />                                                   sulfate trans potentiates VEGFR-mediated angiogenesis. Dev Cell. 2006; 10:625&#226;&#8364;&#8220;634. <br />                                                   [PubMed: 16678777] <br />                                               26. Wang L, Devarajan E, He J, Reddy SP, Dai JL. Transcription repressor activity spleen tyrosine <br />                                                   kinase mediates breast tumor suppression. Cancer Res. 2005; 65:10289&#226;&#8364;&#8220;10297. [PubMed: <br />                                                   16288017] <br />                                               27. Mahabeleshwar GH, Kundu GC. SYK, protein tyrosine kinase, suppresses cell motility and <br />                                                   nuclear factor kappa B-mediated secretion urokinase type plasminogen activator inhibiting <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   phosphatidylinositol 3&#226;&#8364;&#178;-kinase activity breast cancer cells. J Biol Chem. 2003; 278:6209&#226;&#8364;&#8220; <br />                                                   6221. [PubMed: 12477728] <br />                                               28. Chen JN, Haffter P, Odenthal J, Vogelsang E, Brand M, van Eeden FJ, Furutani-Seiki M, Granato <br />                                                   M, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Kelsh RN, Mullins MC, N&#195;&#188;sslein- <br />                                                   Volhard C. Mutations affecting cardiovascular internal organs zebrafish. <br />                                                   Development. 1996; 123:293&#226;&#8364;&#8220;302. [PubMed: 9007249] <br />                                               29. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, <br />                                                   Zeiher AM, Dimmeler S. Involvement Foxo transcription factors angiogenesis postnatal <br />                                                   neovascularization. J Clin Invest. 2005; 115:2382&#226;&#8364;&#8220;2392. [PubMed: 16100571] <br />                                               30. Liu TJ, Lai HC, Ting CT, Wang PH. Bidirectional regulation upstream IGF-I/insulin receptor <br />                                                   signaling downstream FOXO1 cardiomyocytes. J Endocrinol. 2007; 192:149&#226;&#8364;&#8220;158. <br />                                                   [PubMed: 17210752] <br />                                               31. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, <br />                                                   Ramos-Mejia V, Rouleau A, Yang J, Boss&#195;&#169; M, Lajoie G, Bhatia M. IGF FGF cooperatively <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                             Page 12 <br />  <br />  <br />                                                   establish regulatory stem cell niche pluripotent human cells vitro. Nature. 2007; <br />                                                   448:1015&#226;&#8364;&#8220;1021. [PubMed: 17625568] <br />                                               32. Maeng Y, Choi H, Kwon J, Park YW, Choi KS, Min JK, Kim YH, Suh PG, Kang KS, Won MH, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Kim YM, Kwon YG. Endothelial progenitor cell homing: prominent role IGF2-IGF2R- <br />                                                   PLCbeta2 axis. Blood. 2009; 113:233&#226;&#8364;&#8220;243. [PubMed: 18832656] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                          Page 13 <br />  <br />  <br />  <br />                                                                                 CLINICAL PERSPECTIVE <br />                                               Promotion neovasculature holds potential ameliorating coronary artery disease. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               The TOPCARE-AMI (Transplantation Of Progenitor Cells And Regeneration <br />                                               Enhancement Acute Myocardial Infarction) trial indicated circulating endothelial <br />                                               progenitor cells improve left ventricular ejection fraction patients after <br />                                               myocardial infarction. Recent studies demonstrated embryonic stem cells can <br />                                               differentiate functional endothelial cells vasculogenesis, results in <br />                                               functional improvement arises increased neovascularization. The harnessing of <br />                                               vasculogenesis potential revolutionize regenerative medicine contingent <br />                                               means regulate cellular differentiation. In present study, demonstrate that <br />                                               glyco-microenvironment stem cell, specifically sulfated heparan sulfate <br />                                               glycosaminoglycans, plays critical role facilitating vasculogenesis. We confirmed <br />                                               findings vivo larval zebrafish, desulfation heparan sulfate <br />                                               glycosaminoglycans resulted impaired vascular development. The phenotype is <br />                                               rescued exogenous sulfated heparan sulfate glycosaminoglycans. Finally, we <br />                                               identified downstream pathways mediate regulation of <br />                                               vasculogenesis heparan sulfate glycosaminoglycans, including novel FOXO3A/5- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               IGF2 signaling pathway. This study reveals exciting potential harnessing defined <br />                                               cellular glyco-microenvironments directed differentiation precursor cells into <br />                                               endothelial cells, leading neovascularization. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                     Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                        Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                              Figure 1. <br />                                Differentiation ES cells endothelium. A, i&#226;&#8364;&#8220;vi, Quantification endothelial cell transcripts (VE-cadherin, vascular <br />                            endothelial growth factor receptor 2 [VEGFR2], von Willebrand factor [vWF], Tie-2, angiopoietin-2 [Ang2]) stem cell <br />                              marker Oct 4 RT-PCR. B, Bright-field confocal images embryoid bodies stained vWF confirm differentiation <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 endothelial lineage. Images captured LSM510 confocal microscope 488-nm wavelength for <br />                             excitation emission 516 nm. Inset (i&#226;&#8364;&#8220;ii) represents isotype control immunohistochemistry primary antibody <br />                            control. PI indicates propidium iodide. C, RT-PCR analysis revealed expression NDST1 differentiation. D, Western <br />                             blot shows expression NDST1 protein time differentiating embryoid body. E, Compositional analysis HSGAGs <br />                             capillary electrophoresis heparinase digestion revealed negligible sulfated disaccharides day 3 compared day 7, <br />                                    vascular precursors established. The data expressed grades intensity signal the <br />                              electropherogram. Tri-S indicates trisaccharide; Di-S, disaccharide; Mono-S, monosaccharide; Rn, normalized reporter. <br />                                                                      ***P&lt;0.001 compared day 3 control cells. <br />  <br />  <br />  <br />  <br />                                                   Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                          Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                               Figure 2. <br />                            Pharmacological modulation HSGAGs regulates vasculogenesis. A, Typical disaccharide building block HSGAG polymer <br />                              comprises uronic acid glucosamine. It sulfated residue X sulfated acetylated Y. B, Treatment ES <br />                            cells sodium chlorate (Sod. chlorate) inhibited sulfation nascent chain, seen capillary electrophoresis. Data are <br />                               expressed grades intensity signal electropherogram. ND indicates nondetectable; Tri-S, trisaccharide; Di-S, <br />                               disaccharide; Mono-S, monosaccharide. C, Fluorescence-activated cell sorter analysis expression von Willebrand <br />                              factor (vWF) sodium chlorate&#226;&#8364;&#8220;treated embryoid bodies showed concentration-dependent inhibition vasculogenesis (D) <br />                             reversed exogenous heparin. E&#226;&#8364;&#8220;H, Differentiation ES cells endothelial cells inhibited treatment <br />                                heparinase I III sodium chlorate quantified monitoring level transcripts endothelial cell markers <br />                              (vascular endothelial growth factor receptor 2 [VEGFR2], angiopoietin 2 [Ang2], Tie-2, vWF) RT-PCR. **P&lt;0.05, <br />                              **P&lt;0.01, ***P&lt;0.001 compared control. #P&lt;0.01 vs day 3. I, NDST1 gene knocked ESC-EBs 7 days <br />                                 NDST1 shRNA (gray bars), gene expression NDST1 endothelial markers (Tie-2, vWF, Ang2) was <br />                            quantified RT-PCR. GFP shRNA served internal control (black bars). *P&lt;0.05 compared GFP-shRNA. Veh indicates <br />                                                                  vehicle; Rn, normalized reporter; Hep., heparinase. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                    Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                     Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                              Figure 3. <br />                                Morpholino-induced knockdown NDST1 impairs vasculogenesis zebrafish embryo. I-A, BLAST analysis revealed 3 <br />                            zebrafish orthologs zNDST1 chromosome 21 60% sequence identity mouse NDST (mNDST). I-B, A morpholino <br />                            (GTGCATTTAACACTCACCATTCTTC) designed block splice donor site exon 3 (Ex3 Mo). WT indicates wild <br />                                 type. I-C, RT-PCR confirmed effectiveness morpholino dose-dependent manner. Sequencing subcloned <br />                             fragments confirmed altered splicing resulted premature STOP codon. II, Capillary electrophoresis HSGAG profile <br />                                wild-type NDST1 knockdown (NDST1-kd) zebrafish 24 hpf revealed absence sulfated disaccharides the <br />                            NDST1 knockdown compared wild type. Data expressed grades intensity signal electropherogram. <br />  <br />  <br />                                                   Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                     Page 17 <br />  <br />  <br />                            Tri-S indicates trisaccharide; Di-S, disaccharide; Mono-S, monosaccharide; ND, nondetectable. III-A, Morpholino-injected <br />                             tg(Fli1;GFP) fish displayed decreased intersegmental vessels dysmorphic tails dose-dependent manner. III-B, Bright- <br />                              field images T&#195;&#188;bingenAB 48-hpf WT fish (top) 1.15-pmol morpholino&#226;&#8364;&#8220;injected fish. Blood cells accumulated the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             caudal vein plexus morpholino-injected embryos. III-C, Top, 54-hpf tg(Fli:GFP) embryos injected low-dose zNDST1 <br />                            morpholino displayed weaker density tail intersegmental vessels. Bottom, 40-kDa tetramethylrhodamine (TMR) injected into <br />                                                     WT knockdown fish revealed smaller lumens zNDST-injected embryos. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                  Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                      Page 18 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                             Figure 4. <br />                              Exogenous heparin rescues NDST1-knockdown (NDST1-kd) phenotype. A, RT-PCR data showing transcript levels of <br />                             endothelial cell markers, Tie-2 VEGFR2 (vascular endothelial growth factor receptor 2), differentiating ES cells after <br />                             shRNA-induced NDST1 knockdown. Incubation heparin (20 &#206;&#188;g/mL) induced recovery transcript levels NDST1 <br />                            knockdown. Data mean&#194;&#177;SE (n=3). B, Injection heparin zNDST1 morpholino-treated zebrafish resulted partial <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             recovery tail phenotype, used reporter vascularization defects. Graph shows mean tail lengths &#194;&#177;SE 7 8 <br />                                                        fish treatment group. *P&lt;0.05, **P&lt;0.01, ***P&lt;0.001 vs controls. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                  Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                            Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                               Figure 5. <br />                             Temporal transcriptome analysis wild-type (WT) vs NDST1 knockdown zebrafish. A, Heat map created 50 <br />                            significant transcripts according local pooled error testing S-Plus software. Differential expression trends clearly visible <br />                                  WT morphant zebrafish embryos 6-somite, 20-somite, 24-hpf developmental stages. Unidentified <br />                             transcripts denoted Affymetrix identification numbers. B, Hinton plot created independent component analysis <br />                                   robust multichip average (RMA) method&#226;&#8364;&#8220;normalized expression levels reveal gene signatures method is <br />                            independent parametric statistics. Columns represent chips; rows represent latent gene signatures. Colors sizes squares <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                represent direction (positive negative) degree component represented chip. Components <br />                                specific knockdown, developmental stage, individual biological replicates arrowed. Ninety-three percent of <br />                                 transcripts identified differentially expressed local pooled error analysis 0.5% transcripts that <br />                                 contributed independent component analysis component 2, separated WT NDST1 knockdown. C, ANOVA <br />                            analysis (P&lt;0.05) S-Plus revealed 67, 619, 119 regulated transcripts WT morphant RNA 6-somite, 20- <br />                               somite, 24 hpf stages, respectively. The 34 transcripts overlapped developmental stages highlighted the <br />                            Venn diagram. Inset shows confirmation zebrafish FOXO5 IGF2 expression quantitative PCR. D, Cartoon classifying <br />                               transcripts modulated WT NDST1 implicated neovascularization. 6S indicates 6 somite; <br />                                                                           20S, 20 somite; Rn, normalized reporter. <br />  <br />  <br />  <br />  <br />                                                    Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                        Page 20 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                              Figure 6. <br />                              Pathways implicated glycocalyx regulation vasculogenesis. A, At time point, scatterplots compare mean transcript <br />                             abundance 3 wild-type replicates (x axis) 3 zNDST1 morphant replicates (y axis). Those transcripts with <br />                            P&#226;&#8240;&#165;0.01 fold-change &#226;&#8240;&#164;2 Cyber-T analysis 24-hpf time point highlighted green 3 time points. B, C, and <br />                             D, Cell Illustrator Ingenuity pathway analyses used construct pathways significantly regulated transcripts the <br />                            6-somite (6S), 20-somite (20S), 24-hpf developmental stages according Cyber-T analysis. A right-tailed Fisher exact test <br />                            indicated likelihood of pathways constituted random samples 67, 619, 119 transcripts drawn <br />                                                                       Affymetrix microarrays &#226;&#8240;&#165;0.05. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Circulation. Author manuscript; available PMC 2014 April 28. <br />                             Harfouche et al.                                                                                       Page 21 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                                                              Figure 7. <br />                                FOXO3A IGF signaling NDST1-mediated vasculogenesis. A, Graph shows expression FOXO3A transcripts in <br />                             differentiating embryoid bodies function time. B, Transcript levels FOXO3A GFP- NDST1-shRNA&#226;&#8364;&#8220;treated <br />                                 cells quantified RT-PCR. C, Western blot showing levels FOXO3A proteins control (Con) NDST1 <br />                               knockdown ES cells. D, Graph shows transcript levels IGF2 NDST1 knockdown ES cells. E, shRNA-mediated <br />                            knockdown FOXO3A resulted downregulation IGF2, indicated IGF2 downstream FOXO3A. shRNA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            GFP used control. Data shown mean&#194;&#177;SE 3 independent experiments. **P&lt;0.01, ***P&lt;0.001 vs <br />                             <br /> </body></html>